TOP1 and neoplasm: TOP1 inhibition by Topotecan (TPT) or Camptothecin (CPT) has shown anti-tumor effects in xenograft models and clinical trial patients (Du et al., 2018; Tsuchihashi et al., 2020; Spinazzi et al., 2022).